Research links anti-seizure drug to birth defects

07/22/2008 | Bloomberg

The rate of children born with cleft palates or cleft lips was 11 times higher among female patients taking Topamax, Johnson & Johnson's anti-seizure drug, alone or with other medication, according to a study of 203 pregnancies. For boys, a genital defect was 14 times higher than normal. The U.K. researchers said the findings are similar to those from studies of other epilepsy treatments, but a bigger study is necessary to get more conclusive results.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX